Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies: Concise Review.

Prenatal stem cell therapy for inherited diseases: Past, present, and future treatment strategies: Concise Review.

Publication date: Oct 24, 2019

Imagine the profits in quality of life that can be made by treating inherited diseases early in life, maybe even before birth! Immense cost-savings can also be made by treating diseases promptly. Hence, prenatal stem cell therapy holds great promise for developing new and early stage treatment strategies for several diseases. Successful prenatal stem cell therapy would represent a major step forward in the management of patients with hematological, metabolic, or immunological disorders. However, treatment before birth has several limitations, including ethical issues. In this review, we summarize the past, the present, and the future of prenatal stem cell therapy, which includes an overview of different stem cell types, preclinical studies, and clinical attempts treating various diseases. We also discuss the current challenges and future strategies for prenatal stem cell therapy and also new approaches, which may lead to advancement in the management of patients with severe incurable diseases. Stem Cells Translational Medicine 2019.

Concepts Keywords
Hematological Diseases
Imagine Health sciences
Articles
Blood
Hematology
Therapy

Semantics

Type Source Name
gene UNIPROT PTPN5
gene UNIPROT RXFP2
gene UNIPROT EHD1

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *